Type I Interferons Interfere with Liver Glucose Metabolism.
The specific immunological components linking metabolic stresses to liver inflammation and systemic metabolic pathologies in obesity are not entirely known. A recent study (Ghazarian et al., 2017) reveals that obesity-induced type I interferon signaling drives the accumulation and activation of intrahepatic CD8+ T cells, leading to systemic metabolic deterioration.